Davion Healthcare PLC
DAVI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0002039072
In the last 90 days, Davion Healthcare PLC insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysLast 90 days, $36.3K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026
- 0
- 13F valueReported value at the end of Q3 2026
- $0
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 617.7K
- Shares sold short
- Change
- +617.7K
- +100.0% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding DAVI, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding DAVI at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Davion Healthcare PLC insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)10:44 AM ET | Nov 17 | 1 day | King Susan MDirector | PPurchase | +10.0K | $0.98 | +$9.80K | +200.0%15.0K after | Amended |
| Nov 17, 2026 (view filing)8:38 AM ET | Nov 16 | 1 day | Sluyters JulianDirector | PPurchase | +25.0K | $1.06 | +$26.5K | +500.0%30.0K after |
Top 10 13F holders, Q3 2026
View all: Top 10 13F holders, Q3 2026The largest institutional positions in Davion Healthcare PLC at the end of Q3 2026; share changes are against Q2 2026.
No institution reported holding DAVI in 13F filings for Q3 2026.
Holders of 5% or more of DAVI
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Davion Healthcare PLC.